Sign in

CIK 0001087294

  • Non-accelerated filer
  • Smaller reporting company

CUMBERLAND PHARMACEUTICALS INC

Sign in to watch
Ticker
CPIX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
TN
Entity type
Operating
EIN
621765329
Phone
+1 615-255-0068
Business address
1600 WEST END AVENUE, SUITE 1300, NASHVILLE,, TN, 37203
  1. 4 Grant or award Director acquired 4,000 shares (grant or award)
  2. 4 Open-market sale Director sold 8,000 shares at $6.97 ($55,760)
  3. 4 Open-market buy Chief Financial Officer bought 300 shares at $6.95 ($2,085)
  4. 4 Grant or award Director acquired 2,000 shares (grant or award)
  5. 4 Grant or award Director acquired 1,000 shares (grant or award)
  6. 4 Grant or award Director acquired 1,000 shares (grant or award)
  7. 4 Grant or award Director acquired 1,000 shares (grant or award)
  8. 4 Grant or award Director acquired 1,000 shares (grant or award)
  9. 4 Grant or award Director acquired 1,000 shares (grant or award)
  10. 4 Open-market sale Director sold 6,000 shares at $6.40 ($38,400)
  11. 4 Grant or award Sr VP/Chief Commercial Officer acquired 11,600 shares (grant or award)
  12. 4 Grant or award VP and Chief Compliance Office acquired 6,000 shares (grant or award)
  13. 4 Grant or award Chairman and CEO acquired 100,000 shares (grant or award)
  14. 4 Grant or award SVP and Chief Development Off. acquired 10,000 shares (grant or award)
  15. 4 Grant or award Chief Financial Officer acquired 2,500 shares (grant or award)
  16. 4 Open-market buy Chief Financial Officer bought 900 shares at $6.42 ($5,778)
  17. 4 Open-market buy Director bought 15,000 shares at $6.53 ($97,950)
  18. 4 Open-market sale Director sold 20,781 shares at $6.24 ($129,673)
  19. 3 Insider Initial Statement of Ownership
  20. 4 Open-market sale Director sold 18,600 shares at $5.07 ($94,302)

Page 18 of 26 · 512 filings